Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Established and emerging targeted therapies in the myelodysplastic syndromes.

Expert review of hematology - 1 Oct 2016

Canaani Jonathan, Nagler Arnon

Abstract excerpt

INTRODUCTION: Therapy for the myelodysplastic syndromes (MDS) is an evolving area of research which has made significant use of the increased understanding of the complex biology of these disorders. Novel agents targeting multiple pathogenic pathways are being actively tested in preclinical and clinical settings and hold the potential to be available to clinicians before long. AREAS COVERED: Herein we provide an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites, Antineoplastic
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers

Share to Clinical Trials as Topic

Share to Drug Discovery

Share to Epigenesis, Genetic

Share to Molecular Targeted Therapy

Share to Myelodysplastic Syndromes

Source

Identifiers

PMID: 27615383
DOI: 10.1080/17474086.2016.1233054

Genes

PI3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Established and emerging targeted therapies in the myelodysplastic syndromes.PMID 27615383Read ↗

Current and emerging strategies for management of myelodysplastic syndromes.Semantic proximity Read ↗

Society of Hematologic Oncology (SOHO) State of the Art Updates and Next Questions: Myelodysplastic Syndromes.Semantic proximity Read ↗

Molecular Pathogenesis and Treatment of Myelodysplastic Syndromes.Semantic proximity Read ↗

Myelodysplastic syndromes: Updates on Genomic Landscape, Molecular Subtypes, & Targeted Therapies.Semantic proximity Read ↗

Myelodysplastic SyndromesSemantic proximity Read ↗

Current therapeutic approaches for patients with myelodysplastic syndromes.Semantic proximity Read ↗

Myelodysplastic syndromes: recent advancements in risk stratification and unmet therapeutic challenges.Semantic proximity Read ↗

Molecular Targeted Therapy and Immunotherapy for Myelodysplastic SyndromeSemantic proximity Read ↗

Myelodysplastic Syndromes: A New Decade.Semantic proximity Read ↗

The genetics of myelodysplastic syndromes and the opportunities for tailored treatmentsSemantic proximity Read ↗

Myelodysplastic syndromes.Semantic proximity Read ↗

Epigenetics in focus: Pathogenesis of myelodysplastic syndromes and the role of hypomethylating agentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.